Innovent receives NMPA Breakthrough Therapy Designation for IBI343 (anti-CLDN18.2 ADC) as monotherapy for advanced Pancreatic...

Datopotamab deruxtecan granted Priority Review in the US for patients with previously treated advanced EGFR-mutated...

Mersana Therapeutics announces additional FDA Fast Track Designation granted to Emiltatug Ledadotin (XMT-1660)

Celltrion unveils strategic vision for advancing its innovative drug pipeline at the 43rd Annual J.P....

Zai Lab announces positive topline results for TIVDAK in the China subpopulation of the global...

Elevation Oncology provides updates on differentiated ADC programs and upcoming milestones

Daiichi Sankyo acquires Intellectual Property Rights for anti-TAMUC1 antibody in DS-3939 from Glycotope GmbH